Supplementary Figures 1 - 4 from Cancer-Associated CD43 Glycoforms as Target of Immunotherapy

PDF file - 470K, Figure S1. UN1 mAb did not affect the proliferation rate, cell cycle, viability and apoptosis of HPB-ALL cells. Figure S2. The 2/165 phage clone and synthetic peptides do not inhibit the binding of mAb W6/32 to HPB-ALL cells. Supplementary Figure S3. Competition of the UN1 mAb-binding to UN1-positive breast and gastric cancer tissues by the 2/165 phage and G23 peptide. Figure S4. Characterization of affinity-purified antibodies from sera of 2/165 phagotopeimmunized mice.